Miist

Miist Therapeutics is a biotech startup developing a novel inhalation drug delivery platform designed for ultra‐rapid systemic absorption via the lung periphery. They’re initially focusing on smoking cessation and migraine treatment, backed by seed investors, and claim fast onset of action (seconds rather than minutes/hours).